A M Balazuc - JoVE Visualize

Showing results (1-10 of 11) with videos related to

Pageof 2

Sort By:

Developments in Biological Standardization|January 1, 1996

Stabilisation of BCG vaccinesM Gheorghiu, M Lagranderie, A M Balazuc

Annales De Microbiologie|March 1, 1984

[Effect of diffuse light and heat on 8 BCG vaccines prepared from 4 different strains]M Gheorghiu, M Lagranderie, A M Balazuc

Vaccine|January 29, 2000

Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in miceM Lagranderie, P Chavarot, A M Balazuc, et al.

Journal of Virology|March 1, 1997

Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in miceM Lagranderie, A M Balazuc, B Gicquel, et al.

AIDS Research and Human Retroviruses|December 31, 1998

A cocktail of Mycobacterium bovis BCG recombinants expressing the SIV Nef, Env, and Gag antigens induces antibody and cytotoxic responses in mice vaccinated by different mucosal routesM Lagranderie, N Winter, A M Balazuc, et al.

Infection and Immunity|September 19, 2000

Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routesM Abolhassani, M Lagranderie, P Chavarot, et al.

Infection and Immunity|January 1, 1996

Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strainsM R Lagranderie, A M Balazuc, E Deriaud, et al.

Microbes and Infection|July 5, 2005

In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liverA M Balazuc, M Lagranderie, P Chavarot, et al.

Scandinavian Journal of Immunology|April 10, 2002

Development of mixed Th1/Th2 type immune response and protection against Mycobacterium tuberculosis after rectal or subcutaneous immunization of newborn and adult mice with Mycobacterium bovis BCGM Lagranderie, A-M Balazuc, M Abolhassani, et al.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 23, 2008

Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual routeV Lombardi, L Van Overtvelt, S Horiot, et al.

Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:

Pageof 2

Developments in Biological Standardization|January 1, 1996

Stabilisation of BCG vaccinesM Gheorghiu, M Lagranderie, A M Balazuc

Annales De Microbiologie|March 1, 1984

[Effect of diffuse light and heat on 8 BCG vaccines prepared from 4 different strains]M Gheorghiu, M Lagranderie, A M Balazuc

Vaccine|January 29, 2000

Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in miceM Lagranderie, P Chavarot, A M Balazuc, et al.

Journal of Virology|March 1, 1997

Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in miceM Lagranderie, A M Balazuc, B Gicquel, et al.

AIDS Research and Human Retroviruses|December 31, 1998

A cocktail of Mycobacterium bovis BCG recombinants expressing the SIV Nef, Env, and Gag antigens induces antibody and cytotoxic responses in mice vaccinated by different mucosal routesM Lagranderie, N Winter, A M Balazuc, et al.

Infection and Immunity|September 19, 2000

Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routesM Abolhassani, M Lagranderie, P Chavarot, et al.

Infection and Immunity|January 1, 1996

Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strainsM R Lagranderie, A M Balazuc, E Deriaud, et al.

Microbes and Infection|July 5, 2005

In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liverA M Balazuc, M Lagranderie, P Chavarot, et al.

Scandinavian Journal of Immunology|April 10, 2002

Development of mixed Th1/Th2 type immune response and protection against Mycobacterium tuberculosis after rectal or subcutaneous immunization of newborn and adult mice with Mycobacterium bovis BCGM Lagranderie, A-M Balazuc, M Abolhassani, et al.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 23, 2008

Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual routeV Lombardi, L Van Overtvelt, S Horiot, et al.

Pageof 2